Remarkably, the IFNAR2 region on chromosome 21q22.11 has been repeatedly associated with severe COVID-19 in multiple GWAS and meta-analyses, and integrative genetics studies suggest that variation at this locus may influence disease risk via effects on interferon signaling and immune cell gene expression. The gene discussed is IFNAR2; the disease is COVID-19.